<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0335">
 <label>67••</label>
 <element-citation publication-type="journal" id="sbref0335">
  <person-group person-group-type="author">
   <name>
    <surname>Simmons</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Gosalia</surname>
    <given-names>D.N.</given-names>
   </name>
   <name>
    <surname>Rennekamp</surname>
    <given-names>A.J.</given-names>
   </name>
   <name>
    <surname>Reeves</surname>
    <given-names>J.D.</given-names>
   </name>
   <name>
    <surname>Diamond</surname>
    <given-names>S.L.</given-names>
   </name>
   <name>
    <surname>Bates</surname>
    <given-names>P.</given-names>
   </name>
  </person-group>
  <article-title>Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry</article-title>
  <source>Proc Natl Acad Sci U S A</source>
  <volume>102</volume>
  <year>2005</year>
  <fpage>11876</fpage>
  <lpage>11881</lpage>
  <pub-id pub-id-type="pmid">16081529</pub-id>
 </element-citation>
 <note>
  <p>First report that demonstrates cathepsin L is required for SARS-CoV entry, and therefore stands as a potential antiviral target.</p>
 </note>
</ref>
